Evidence map›Paper›PMID 28160560›Full record

ArticleOncotarget2017

Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.

Julie V Philley, Anbarasu Kannan, David E Griffith, Megan S Devine, Jeana L Benwill, Richard J Wallace, Barbara A Brown-Elliott, Foram Thakkar, Varsha Taskar, James G Fox and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.Advances in experimental medicine and biology · 2021
    Article
  7. Article
  8. Article
  9. The Emerging Role of Adiponectin in Female Malignancies.International journal of molecular sciences · 2019
    Review
  10. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.International journal of molecular sciences · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Julie V PhilleyDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Anbarasu KannanCellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Texas, USA.
David E GriffithDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Megan S DevineDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Jeana L BenwillDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Richard J WallaceDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Barbara A Brown-ElliottThe Mycobacteria/Nocardia Research Laboratory Department of Microbiology, The University of Texas Health Science Center at Tyler, Texas, USA.
Foram ThakkarDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Varsha TaskarDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
James G FoxDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Ammar AlqaidDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Hernaina BainsDepartment of Medicine, The University of Texas Health Science Center at Tyler, Texas, USA.
Sudeep GuptaMedical Oncology, Tata Memorial Center, Mumbai, India.
Santanu DasguptaCellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Texas, USA.
The University of Texas Health Science Center at Tyler · USTata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bronchiectasis Nontuberculous mycobacterium (NTMnb) infection is an emerging health problem in breast cancer (BCa) patients. We measured sera exosome proteome in BCa-NTMnb subjects and controls by Mass Spectroscopy. Extracellular matrix protein 1 (ECM1) was detected exclusively in the circulating exosomes of 82% of the BCa-NTMnb cases. Co-culture of ECM1+ exosomes with normal human mammary epithelial cells induced epithelial to mesenchymal transition accompanied by increased Vimentin/CDH1 expression ratio and Glutamate production. Co-culture of the ECM1+ exosomes with normal human T cells modulated their cytokine production. The ECM1+ exosomes were markedly higher in sera obtained from BCa-NTMnb subjects. Exclusive expression of APN, APOC4 and AZGP1 was evident in the circulating exosomes of these BCa-NTMnb cases, which predicts disease prevalence independent of the body max index in concert with ECM1. Monitoring ECM1, APN, APOC4 and AZGP1 in the circulating exosomes could be beneficial for risk assessment, monitoring and surveillance of BCa-NTMnb.

Indexed as

AgedAged, 80 and overBlotting, WesternBreast NeoplasmsBronchiectasisCoculture TechniquesEpithelial-Mesenchymal TransitionExosomesExtracellular Matrix ProteinsFemaleFlow CytometryFluorescent Antibody TechniqueHumansMass SpectrometryMiddle AgedMycobacterium InfectionsECM1 protein, humanExtracellular Matrix Proteinsbiomarkerbreast cancerECM1exosomesnontuberculous Mycobacterium

Identifiers

PMID28160560
PMCPMC5392308
OpenAlexW2585510165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.